Medicure Statistics

Total Valuation

Medicure has a market cap or net worth of CAD 12.84 million. The enterprise value is 6.50 million.

Market Cap	12.84M
Enterprise Value	6.50M

Important Dates

The next estimated earnings date is Wednesday, August 20, 2025.

Earnings Date	Aug 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Medicure has 10.44 million shares outstanding. The number of shares has decreased by -0.33% in one year.

Current Share Class	10.44M
Shares Outstanding	10.44M
Shares Change (YoY)	-0.33%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.27%
Owned by Institutions (%)	0.62%
Float	5.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.59
PB Ratio	0.64
P/TBV Ratio	1.78
P/FCF Ratio	n/a
P/OCF Ratio	5.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.64
EV / Sales	0.30
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.04.

Current Ratio	1.71
Quick Ratio	1.26
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-76.49

Financial Efficiency

Return on equity (ROE) is -8.79% and return on invested capital (ROIC) is -9.34%.

Return on Equity (ROE)	-8.79%
Return on Assets (ROA)	-6.71%
Return on Invested Capital (ROIC)	-9.34%
Return on Capital Employed (ROCE)	-15.27%
Revenue Per Employee	570,974
Profits Per Employee	-46,947
Employee Count	38
Asset Turnover	0.74
Inventory Turnover	2.59

Taxes

In the past 12 months, Medicure has paid 263,000 in taxes.

Income Tax	263,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.13% in the last 52 weeks. The beta is 0.88, so Medicure's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+5.13%
50-Day Moving Average	1.04
200-Day Moving Average	0.91
Relative Strength Index (RSI)	66.65
Average Volume (20 Days)	1,010

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicure had revenue of CAD 21.70 million and -1.78 million in losses. Loss per share was -0.17.

Revenue	21.70M
Gross Profit	12.32M
Operating Income	-3.14M
Pretax Income	-1.52M
Net Income	-1.78M
EBITDA	-1.42M
EBIT	-3.14M
Loss Per Share	-0.17

Full Income Statement

Balance Sheet

The company has 7.22 million in cash and 876,000 in debt, giving a net cash position of 6.34 million or 0.61 per share.

Cash & Cash Equivalents	7.22M
Total Debt	876,000
Net Cash	6.34M
Net Cash Per Share	0.61
Equity (Book Value)	20.10M
Book Value Per Share	1.93
Working Capital	6.55M

Full Balance Sheet

Cash Flow

Operating Cash Flow	2.17M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 56.76%, with operating and profit margins of -14.45% and -8.22%.

Gross Margin	56.76%
Operating Margin	-14.45%
Pretax Margin	-7.01%
Profit Margin	-8.22%
EBITDA Margin	-6.55%
EBIT Margin	-14.45%
FCF Margin	n/a

Dividends & Yields

Medicure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.33%
Shareholder Yield	n/a
Earnings Yield	-13.90%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.

Last Split Date	Nov 2, 2012
Split Type	Reverse
Split Ratio	0.0666666

Scores

Medicure has an Altman Z-Score of -1.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.9
Piotroski F-Score	2